We are live on
!
Find out more
BC
Brahman Capital Portfolio holdings
AUM
$275M
1-Year Est. Return
18.08%
This Fund
S&P 500
This Quarter
Est. Return
+1.07%
1 Year Est. Return
+18.08%
3 Year Est. Return
+16.57%
5 Year Est. Return
+65.78%
10 Year Est. Return
+289.43%
AUM
$1.05B
AUM Growth
-$361M
(-26%)
Cap. Flow
-$356M
Cap. Flow
% of AUM
-33.82%
Top 10 Holdings %
Top 10 Hldgs %
95.67%
Holding
15
New
2
Increased
1
Reduced
10
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fox Class A
FOXA
|
+$22.1M |
| 2 |
CCX.U
Churchill Capital Corp II
CCX.U
|
+$20.3M |
| 3 |
Euronet Worldwide
EEFT
|
+$17.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$111M |
| 2 |
Hilton Worldwide
HLT
|
+$66.1M |
| 3 |
IQVIA
IQV
|
+$41.8M |
| 4 |
Clarivate
CLVT
|
+$35.4M |
| 5 |
TIF
Tiffany & Co.
TIF
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 21.93% |
| 2 | Technology | 20.56% |
| 3 | Utilities | 20.07% |
| 4 | Healthcare | 12.82% |
| 5 | Financials | 9.51% |
Similar funds
TFA
PWM
AEPLI
DT
RCGI
IAM
RBGI
T
Brahman Capital's Q2 2019 Portfolio in Review
As of Q2 2019, Brahman Capital held 15 positions worth $1.05B, down 26% from $1.41B the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Brahman Capital withdrew a net $356M in Q2 2019, closing 2 positions and reducing 10 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 22% of assets, up from 16% a quarter earlier, followed by Technology and Utilities.
Against the trend, Brahman Capital opened a new position in Churchill Capital Corp II worth $20.3M.
- Brahman Capital's largest Q2 2019 buy was Churchill Capital Corp II: 2,000,000 shares worth $20.3M.
- Brahman Capital added most to Fox Class A in Q2 2019, an estimated $22.1M increase.
- Brahman Capital's biggest Q2 2019 reduction was IQVIA, cutting an estimated $41.8M.
- Brahman Capital fully exited Teva Pharmaceuticals in Q2 2019, selling an estimated $111M.
- Brahman Capital's ten largest holdings make up 96% of its $1.05B portfolio in Q2 2019.
- Brahman Capital opened 2 new positions and closed 2 in Q2 2019.
- Brahman Capital's portfolio value fell 26% quarter-over-quarter to $1.05B.
Based on Brahman Capital's 13F filing for Q2 2019, filed 14 Aug 2019.